HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fields, M. L. Articles by Erikson, J. Search for Related Content PubMed PubMed Citation Articles by Fields, M. L. Articles by Erikson, J.

Fas/Fas Ligand Deficiency Results in Altered Localization of Anti-Double-Stranded DNA B Cells and Dendritic Cells¹

Michele L. Fields^*, Caroline L. Sokol^*, Ashlyn Eaton-Bassiri^*, Su-jean Seo^*, Michael P. Madaio and Jan Erikson^2,*

^* Wistar Institute, Philadelphia, PA 19104; and Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104

Autoantibodies directed against dsDNA are found in patients with systemic lupus erythematosus as well as in mice functionally deficient in either Fas or Fas ligand (FasL) (lpr/lpr or gld/gld mice). Previously, an IgH chain transgene has been used to track anti-dsDNA B cells in both nonautoimmune BALB/c mice, in which autoreactive B cells are held in check, and MRL-lpr/lpr mice, in which autoantibodies are produced. In this study, we have isolated the Fas/FasL mutations away from the autoimmune-prone MRL background, and we show that anti-dsDNA B cells in Fas/FasL-deficient BALB/c mice are no longer follicularly excluded, and they produce autoantibodies. Strikingly, this is accompanied by alterations in the frequency and localization of dendritic cells as well as a global increase in CD4 T cell activation. Notably, as opposed to MRL-lpr/lpr mice, BALB-lpr/lpr mice show no appreciable kidney pathology. Thus, while some aspects of autoimmune pathology (e.g., nephritis) rely on the interaction of the MRL background with the lpr mutation, mutations in Fas/FasL alone are sufficient to alter the fate of anti-dsDNA B cells, dendritic cells, and T cells.

This article has been cited by other articles:

				R. T. Robinson, J. Wang, J. G. Cripps, M. W. Milks, K. A. English, T. A. Pearson, and J. D. Gorham End-Organ Damage in a Mouse Model of Fulminant Liver Inflammation Requires CD4+ T Cell Production of IFN-{gamma} but Is Independent of Fas J. Immunol., March 1, 2009; 182(5): 3278 - 3284. [Abstract] [Full Text] [PDF]

				T. Izawa, N. Ishimaru, K. Moriyama, M. Kohashi, R. Arakaki, and Y. Hayashi Crosstalk between RANKL and Fas signaling in dendritic cells controls immune tolerance Blood, July 1, 2007; 110(1): 242 - 250. [Abstract] [Full Text] [PDF]

				E. Paul, A. Nelde, A. Verschoor, and M. C. Carroll Follicular exclusion of autoreactive B cells requires Fc{gamma}RIIb Int. Immunol., April 1, 2007; 19(4): 365 - 373. [Abstract] [Full Text] [PDF]

				B. D. Hondowicz, S. T. Alexander, W. J. Quinn III, A. J. Pagan, M. H. Metzgar, M. P. Cancro, and J. Erikson The role of BLyS/BLyS receptors in anti-chromatin B cell regulation Int. Immunol., April 1, 2007; 19(4): 465 - 475. [Abstract] [Full Text] [PDF]

				S. Wan, C. Xia, and L. Morel IL-6 Produced by Dendritic Cells from Lupus-Prone Mice Inhibits CD4+CD25+ T Cell Regulatory Functions J. Immunol., January 1, 2007; 178(1): 271 - 279. [Abstract] [Full Text] [PDF]

				M. L. Fields, M. H. Metzgar, B. D. Hondowicz, S.-A. Kang, S. T. Alexander, K. D. Hazard, A. C. Hsu, Y.-Z. Du, E. L. Prak, M. Monestier, et al. Exogenous and Endogenous TLR Ligands Activate Anti-Chromatin and Polyreactive B Cells. J. Immunol., June 1, 2006; 176(11): 6491 - 6502. [Abstract] [Full Text] [PDF]

				M. Chen, Y.-H. Wang, Y. Wang, L. Huang, H. Sandoval, Y.-J. Liu, and J. Wang Dendritic cell apoptosis in the maintenance of immune tolerance. Science, February 24, 2006; 311(5764): 1160 - 1164. [Abstract] [Full Text] [PDF]

				M. L. Fields, B. D. Hondowicz, M. H. Metzgar, S. A. Nish, G. N. Wharton, C. C. Picca, A. J. Caton, and J. Erikson CD4+CD25+ Regulatory T Cells Inhibit the Maturation but Not the Initiation of an Autoantibody Response J. Immunol., October 1, 2005; 175(7): 4255 - 4264. [Abstract] [Full Text] [PDF]

				M. L. Fields, S. A. Nish, B. D. Hondowicz, M. H. Metzgar, G. N. Wharton, A. J. Caton, and J. Erikson The Influence of Effector T Cells and Fas Ligand on Lupus-Associated B Cells J. Immunol., July 1, 2005; 175(1): 104 - 111. [Abstract] [Full Text] [PDF]

				M. A. Steeves and T. N. Marion Tolerance to DNA in (NZB x NZW)F1 Mice That Inherit an Anti-DNA VH as a Conventional {micro} H Chain Transgene but Not as a VH Knock-in Transgene J. Immunol., June 1, 2004; 172(11): 6568 - 6577. [Abstract] [Full Text] [PDF]

				T. Yoneda, N. Ishimaru, R. Arakaki, M. Kobayashi, T. Izawa, K. Moriyama, and Y. Hayashi Estrogen Deficiency Accelerates Murine Autoimmune Arthritis Associated with Receptor Activator of Nuclear Factor-{kappa}B Ligand-Mediated Osteoclastogenesis Endocrinology, May 1, 2004; 145(5): 2384 - 2391. [Abstract] [Full Text] [PDF]

				E. H. Ekland, R. Forster, M. Lipp, and J. G. Cyster Requirements for Follicular Exclusion and Competitive Elimination of Autoantigen-Binding B Cells J. Immunol., April 15, 2004; 172(8): 4700 - 4708. [Abstract] [Full Text] [PDF]

				K Haugbro, J C Nossent, T Winkler, Y Figenschau, and O P Rekvig Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity Ann Rheum Dis, April 1, 2004; 63(4): 386 - 394. [Abstract] [Full Text] [PDF]